IXICO plc (PHYOF)

Revenue by Product

Financials in millions GBX. Fiscal year is October - September.

Year Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Aug 31, 2006	Aug 31, 2005	Aug 31, 2004
Clinical Trials Services	5.77M
Clinical Trials Services Growth	-13.49%

Revenue by Geography

Financials in millions GBX. Fiscal year is October - September.

Year Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Aug 31, 2006	Aug 31, 2005	Aug 31, 2004
United States	2.37M
United States Growth	-22.54%
United Kingdom	1.33M
United Kingdom Growth	39.71%
Netherlands	742.00K
Netherlands Growth	-13.92%
Ireland	557.00K
Ireland Growth	-19.16%
Switzerland	500.00K
Switzerland Growth	-38.73%
Europe	272.00K
Europe Growth	-7.17%